Needham sees the medtech sector growing by 7% in 2023 versus 5.7% last year, despite slowed growth in Q2, helped by double-digit growth in certain cardiology categories.
The investment bank noted that medtech growth slowed slightly in Q2, expanding by only 8.3% compared with 8.9% in Q1, but still beat its Q2 forecast of 5%. And despite forecasting a 7% increase for 2023, the bank sees growth slipping to 5.3% in 2024.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased